Advertisement
Loading...

Axsome Therapeutics, Inc.

AXSM•NASDAQ
Healthcare
Biotechnology
$226.38
$-8.94(-3.80%)
U.S. Market is Open • 15:41

Axsome Therapeutics, Inc. (AXSM) Stock Overview

Explore Axsome Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12B
P/E Ratio-62.97
EPS (TTM)$-3.72
ROE-2.60%
Fundamental Analysis

AI Price Forecasts

1 Month$142.27
3 Months$175.41
1 Year Target$170.02

AXSM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Axsome Therapeutics, Inc. (AXSM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.03, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $170.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -62.97 and a market capitalization of 12B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.30%
5-Day Change
5.31%
1-Month Change
26.11%
3-Month Change
28.18%
6-Month Change
66.28%
Year-to-Date (YTD) Change
27.17%
1-Year Change
124.05%
3-Year Change
198.66%
5-Year Change
297.59%
All-Time (Max) Change
2557.55%

Contact Information

https://www.axsome.com
212 332 3241
22 Cortlandt Street, New York City, NY, 10007

Company Facts

712 Employees
IPO DateNov 19, 2015
CountryUS
Actively Trading

Frequently Asked Questions